Ensysce Biosciences (ENSC) Misses Q1 EPS by 139c

Ensysce Biosciences (NASDAQ: ENSC) reported Q1 EPS of ($1.39). Revenue for the quarter came in at $1.32 million.

For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.

You May Also Be Interested In

• Musalem: strong growth and investment influencing bond market - CNBC
• Deere conference call: 2027 orders up mid-single digits from last year)
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth